GlaxoSmithkline Consumer Healthcare (Delisted) share news and announcements

BSE: 500676

Formerly Smithkline Beecham Consumer Healthcare

Last traded ₹10,732.60 on 15 Apr 2020

Delisted on 24 Jun 2021.

GlaxoSmithkline Consumer Healthcare share news and announcements

668 announcements, routine notices left out, newest first. Page 3 of 14.

Apr 2019
- 10 Apr · Statement Of Investor Complaints For The Quarter Ended March 2019
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 16 16 <td class='TTRow'
- 10 Apr · Business
  Dear Sir / Madam, In compliance with the Regulation 40(9) & 40(10) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, please find attached herewith the .... (opens in a new tab)
- 8 Apr · Legal
  Exchange had sought clarification from the Company with respect to news item captioned- "Maharashtra FDA notice for Colgate brand Sensodyne for misleading consumers". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been announced to the Exchanges under Regulation 30 of Listing Regulations. If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under Regulation 30 of the Listing Regulations. The response from the Company is attached. (opens in a new tab)
  The exchange asked on 5 Apr 2019
- 8 Apr · Reply To Your Query Dated April 05, 2019
  This is in response to your query on the media report, 'Maharashtra FDA notice for Colgate brand, Sensodyne for 'misleading consumers'. We would like to inform you that GlaxoSmithKline .... (opens in a new tab)
- 8 Apr · Legal
  Exchange had sought clarification from GlaxoSmithkline Consumer Healthcare Ltd with reference to the media report, "Maharashtra FDA notice for Colgate brand, Sensodyne for 'misleading ....
- 5 Apr · Legal
  Exchange has sought clarification from GlaxoSmithkline Consumer Healthcare Ltd with respect to news article appearing on www.hindustantimes.com April 05, 2019, titled "Maharashtra FDA ....
Mar 2019
- 12 Mar · Meeting
  Notice of Postal Ballot / e-voting ("Notice") which has been .... (opens in a new tab)
- 12 Mar · Meeting
  Notice of Postal Ballot (opens in a new tab)
Feb 2019
- 15 Feb · Advance Intimation Under Regulation 39(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent .... (opens in a new tab)
- 14 Feb · Results
  Financial results for the period ended December 31, 2018. (opens in a new tab)
- 14 Feb · Results
  We would like to inform you that the Board of Directors in its meeting held on .... (opens in a new tab)
- 13 Feb · Analysts
  Details of Analyst / Institutional Investors Meeting to be held on Friday, .... (opens in a new tab)
- 13 Feb · Analysts
  Analysts/Institutional Investor Meet/Con. Call Updates (opens in a new tab)
- 7 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2018 (opens in a new tab)
- 7 Feb · Board meeting
  GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve Pursuant .... (opens in a new tab)
- 1 Feb · Advance Intimation Under Regulation 39(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent .... (opens in a new tab)
Jan 2019
- 30 Jan · Advance Intimation Under Regulation 39(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent .... (opens in a new tab)
- 25 Jan · Business
  Approval of the Competition Commission of India to the proposed amalgamation of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited. Disclosure under Regulation 30(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (opens in a new tab)
- 25 Jan · Business
  This is in continuation of our earlier intimation dated December 3, 2018, wherein it was informed that the Board of Directors of GlaxoSmithKline Consumer Healthcare Limited (the 'Company') .... (opens in a new tab)
- 25 Jan · Advance Intimation Under Regulation 39(3) As SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent .... (opens in a new tab)
- 24 Jan · Advance Intimation Under Regulation 39(3) As SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent .... (opens in a new tab)
- 21 Jan · Advance Intimation Under Regulation 39(3) As SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent .... (opens in a new tab)
- 11 Jan · Advance Intimation Under Regulation 39(3) As SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent .... (opens in a new tab)
- 8 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 13 13 <td class='TTRow'
- 8 Jan · Shareholding for the Period Ended December 31, 2018
  Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click ....
- 7 Jan · Advance Intimation Under Regulation 39(3) As SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent .... (opens in a new tab)
- 3 Jan · Advance Intimation Under Regulation 39(3) As SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  We would like to inform you that Registrar and Transfer Agent of Company M/s. Karvy .... (opens in a new tab)
Dec 2018
- 28 Dec · Advance Intimation Under Regulation 39(3) As SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent .... (opens in a new tab)
- 22 Dec · Results
  Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 21 Dec · Meeting
  Copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. (opens in a new tab)
- 21 Dec · Results
  In pursuance to Regulation 44 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('LODR') and Section 110 and 108 of the Companies Act, 2013 read with Rule 20 and .... (opens in a new tab)
- 13 Dec · Advance Intimation Under Regulation 39(3) As SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent .... (opens in a new tab)
- 12 Dec · Advance Intimation Under Regulation 39(3) As SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent .... (opens in a new tab)
- 4 Dec · Registrar & Share Transfer Agent Update
  Registrar & Share Transfer Agent UpdateThe Company has been informed that pursuant to Order of the Hyderabad Bench of the National Company Law Tribunal (NCLT Order), the operations of Karvy Computershare Private Limited, the Share Transfer Agents of the Company (KCPL) have been transferred to Karvy Fintech Private Limited (Karvy Fintech) with effect from November 17, 2018. The Company has been further informed that pursuant to the NCLT Order all the existing agreements to which KCPL is a party including the agreements entered into by the Company shall be in full force and vest with Karvy Fintech Private Limited We request you to take note of the same and update the name of Karvy Fintech Private Limited as the Share Transfer Agents of the Company in your records.We request you to take the above information on record. (opens in a new tab)
- 4 Dec · Announcement under Regulation 30 (LODR)-Change in RTA
  Company has been informed that pursuant to Order of the Hyderabad Bench of the National Company Law Tribunal (NCLT Order), the operations of Karvy Computershare Private Limited, the .... (opens in a new tab)
- 3 Dec · Business
  Board of Directors of GlaxoSmithKline Consumer Healthcare Limited (the Company) in its meeting held on December 03, 2018 considered and approved a scheme of amalgamation between the Company and Hindustan Unilever Limited ( HUL), and their respective shareholders and creditors ( Scheme) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. (opens in a new tab)
- 3 Dec · Business
  We wish to inform you that the Board of Directors of GlaxoSmithKline Consumer Healthcare .... (opens in a new tab)
Nov 2018
- 29 Nov · Clarifies on news item
  With reference to news appeared in "www.livemint.com" dated November 29, 2018 quoting "Unilever nears deal to add Horlicks to its mix", GlaxoSmithkline Consumer Healthcare Ltd has submitted .... (opens in a new tab)
- 29 Nov · News Verification
  Exchange has sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to recent news item captioned "Unilever may pip Nestle to buy GSK's India unit.". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. GlaxoSmithKline Consumer Healthcare Limited has submitted their response. (opens in a new tab)
- 29 Nov · News Verification
  Exchange has sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to recent news item captioned "Unilever may pip Nestle to buy GSK's India unit.". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
- 29 Nov · Legal
  Exchange has sought clarification from GlaxoSmithkline Consumer Healthcare Ltd on November 29, 2018 with reference to news appeared in "www.livemint.com" dated November 29, 2018 quoting ....
- 22 Nov · Meeting
  This letter is w.r.t your e-mail dated November 21, 2018 seeking clarifications on the date by which the Postal Ballot results will be declared by the Company and disclosure of the .... (opens in a new tab)
- 19 Nov · Meeting
  Notice of Postal Ballot (opens in a new tab)
- 19 Nov · Meeting
  Notice of Postal Ballot / e-voting ("Notice") which has been .... (opens in a new tab)
- 1 Nov · Results
  Financial results for the period ended September 30, 2018. (opens in a new tab)
- 1 Nov · Results
  We would like to inform you that the Board of Directors in its meeting held on .... (opens in a new tab)
- 1 Nov · Analysts
  Analysts/Institutional Investor Meet/Con. Call UpdatesPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, the details of Analyst / Institutional Investors Meeting to be held on Friday, November 02, 2018 is as follows: Type of Meeting Time of Event Dial - in DetailsConference Call 1200 hours (IST) India +91 22 6280 1145/ +91 22 7115 8046 Hong Kong 800 964 448 Singapore 800 101 2045 UK 0 808 101 1573 USA 1 866 746 2133The above is for your information. Please take the above on your records. (opens in a new tab)
- 1 Nov · Analysts
  Details of Analyst / Institutional Investors Meeting to be held on Friday, November .... (opens in a new tab)
Oct 2018
- 23 Oct · Results
  Meeting of the Board of Directors will be held on November 01, 2018, inter alia, to consider and take on record the Unaudited .... (opens in a new tab)
- 22 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2018 (opens in a new tab)